THERAVANCE $35.34

down -0.38


19/6/2013 11:19 AM  |  NASDAQ : THRX  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/20/2011 Aguiar Michael W Sr VP, Chief Financial Officer -2,527 $25.48 -1.16%
5/20/2011 Brinkley David L Head of Business Dev. -1,883 $25.48 -1.91%
5/20/2011 Shafer Bradford J Sr VP, Gen. Counsel, Secretary -2,116 $25.48 -0.61%
5/20/2011 Mammen Mathai SVP, Research & Early Clin Dev -2,245 $25.48 -0.90%
5/11/2011 Winningham Rick E Chief Executive Officer -73,100 $26.28 -13.08%
5/10/2011 Winningham Rick E Chief Executive Officer -54,646 $26.41 -8.91%
5/3/2011 GLAXOSMITHKLINE PLC TenPercent 261,299 $25.60 4.43%
3/16/2011 Brinkley David L Head of Business Dev. -2,100 $22.02 -2.09%
3/16/2011 Brinkley David L Head of Business Dev. 2,100 $3.10 2.13%
3/15/2011 Brinkley David L Head of Business Dev. -45,492 $22.08 -31.62%
3/15/2011 Brinkley David L Head of Business Dev. 3,290 $3.10 2.41%
3/15/2011 Brinkley David L Head of Business Dev. 38,271 $8.53 38.90%
3/15/2011 Brinkley David L Head of Business Dev. 3,931 $3.10 2.81%
3/11/2011 Shafer Bradford J Sr VP, Gen. Counsel, Secretary -6,451 $22.75 -100.00%
3/11/2011 Shafer Bradford J Sr VP, Gen. Counsel, Secretary -20,238 $22.76 -5.51%
3/7/2011 YOUNG WILLIAM D Director -5,376 $22.31 -13.61%
3/7/2011 YOUNG WILLIAM D Director 10,752 $8.53 37.39%
3/1/2011 Winningham Rick E Chief Executive Officer -63,873 $22.53 -9.43%
2/28/2011 Winningham Rick E Chief Executive Officer -29,800 $22.49 -4.00%
2/28/2011 Winningham Rick E Chief Executive Officer 101,752 $8.53 15.83%
2/28/2011 Winningham Rick E Chief Executive Officer -37,200 $23.49 -5.20%
2/25/2011 Winningham Rick E Chief Executive Officer -42,000 $22.74 -6.13%
2/25/2011 Winningham Rick E Chief Executive Officer -50,200 $22.22 -6.83%
2/25/2011 Winningham Rick E Chief Executive Officer 135,850 $8.53 22.67%
2/24/2011 Winningham Rick E Chief Executive Officer -93,100 $21.45 -13.45%
2/24/2011 Winningham Rick E Chief Executive Officer 135,950 $8.53 24.44%
2/23/2011 Winningham Rick E Chief Executive Officer 142,500 $8.53 27.87%
2/23/2011 Winningham Rick E Chief Executive Officer -97,600 $21.14 -14.93%
2/22/2011 Winningham Rick E Chief Executive Officer 11,729 $8.53 2.78%
2/22/2011 Winningham Rick E Chief Executive Officer -158,500 $21.43 -23.30%
2/22/2011 Winningham Rick E Chief Executive Officer -10,300 $22.15 -1.97%
2/22/2011 Winningham Rick E Chief Executive Officer 246,411 $8.53 56.81%
2/20/2011 Aguiar Michael W Sr VP, Chief Financial Officer -3,511 $22.50 -1.58%
2/20/2011 Winningham Rick E Chief Executive Officer -6,790 $22.50 -1.58%
2/20/2011 Mammen Mathai SVP, Research & Early Clin Dev -3,240 $22.50 -1.28%
2/20/2011 Brinkley David L Head of Business Dev. -2,480 $22.50 -2.46%
2/20/2011 Shafer Bradford J Sr VP, Gen. Counsel, Secretary -3,111 $22.50 -0.84%
2/18/2011 YOUNG WILLIAM D Director -5,376 $23.22 -15.75%
2/18/2011 GLAXOSMITHKLINE PLC TenPercent 152,278 $23.70 2.65%
2/18/2011 YOUNG WILLIAM D Director 10,752 $8.53 45.99%
2/18/2011 Mammen Mathai SVP, Research & Early Clin Dev -3,701 $23.12 -1.44%
1/28/2011 Mammen Mathai SVP, Research & Early Clin Dev 9,838 $8.53 7.34%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (THRX), click here.
Marketplace
Trading Center